Irwin Naturals Inc.
IWINFOTCHealthcare
$0.50
+$0.17(+51.52%)
Market Cap$1684685
P/E Ratio—
52W High$1.07
52W Low$0.05
Irwin Naturals Inc. (IWINF) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
IWINF · earnings · updated Jun 9, 2026
Latest Earnings
Q4 FY2023Report Date: Nov 23, 2023EPS Actual
-$0.56
Est. -$0.18 · -211.1%
Revenue
$0.02B
Est. $0.02B · -6.2%
Fiscal Period
Q4 FY2023
FY ends December
Report Date
Nov 23, 2023
After Market Close
▼ Miss EPS▼ Miss Revenue
IWINF reports quarterly as a OTC-listed Medical - Pharmaceuticals company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
84
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
$93.32
Rev. $1001.5B
Days Away84
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.$93.32
Rev. Est.$1001.5B
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ◌ Q3 FY2024 | Aug 12, 2024 | — | — | — | — | $0.02B | — |
| ◌ Q2 FY2024 | May 30, 2024 | — | — | — | — | $0.02B | — |
| ▼ Q4 FY2023 | Nov 23, 2023 | -$0.18 | -$0.56 | -211.1% | $0.02B | $0.02B | -6.2% |
| — Q3 FY2023 | Aug 25, 2023 | — | -$1.57 | — | $0.02B | $0.02B | +0.0% |
| ▼ Q2 FY2023 | Jun 1, 2023 | -$0.01 | -$2.27 | -22806.2% | $0.02B | $0.02B | -6.6% |
| — Q4 FY2022 | Dec 31, 2022 | — | -$1.56 | — | $0.02B | — | — |
| — Q4 FY2022 | Nov 30, 2022 | — | -$0.39 | — | $0.02B | — | — |
| ▼ Q2 FY2022 | May 30, 2022 | $0.80 | $0.00 | -100.0% | $0.02B | $0.03B | -20.9% |
Q3 FY2024
Aug 12, 2024
EPS Actual
—
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q2 FY2024
May 30, 2024
EPS Actual
—
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q4 FY2023
Nov 23, 2023Miss
EPS Actual
-$0.56
EPS Est.
-$0.18
EPS Surpr.
-211.1%
Revenue
$0.02B
Q3 FY2023
Aug 25, 2023
EPS Actual
-$1.57
EPS Est.
—
EPS Surpr.
—
Revenue
$0.02B
Q2 FY2023
Jun 1, 2023Miss
EPS Actual
-$2.27
EPS Est.
-$0.01
EPS Surpr.
-22806.2%
Revenue
$0.02B
Q4 FY2022
Dec 31, 2022
EPS Actual
-$1.56
EPS Est.
—
EPS Surpr.
—
Revenue
$0.02B
Q4 FY2022
Nov 30, 2022
EPS Actual
-$0.39
EPS Est.
—
EPS Surpr.
—
Revenue
$0.02B
Q2 FY2022
May 30, 2022Miss
EPS Actual
$0.00
EPS Est.
$0.80
EPS Surpr.
-100.0%
Revenue
$0.02B
Analyst Estimates
Limited analyst coverage (fewer than 3 analysts). Estimates may not reflect market consensus.
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q1 FY2024 | $0.00 | $0.00 | $0.00 | 0 |
| Q4 FY2023 | $-0.83 | $-0.83 | $-0.83 | 1 |
| Q3 FY2023 | $0.00 | $0.00 | $0.00 | 0 |
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q1 FY2024 | $0.0B | $0.0B | $0.0B | 1 |
| Q4 FY2023 | $0.0B | $0.0B | $0.0B | 1 |
| Q3 FY2023 | $0.0B | $0.0B | $0.0B | 1 |
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| ▼ Q4 FY2023 | Nov 23, 2023 | -211.1% | $0.24 | $0.24 | +0.00% |
| — Q3 FY2023 | Aug 25, 2023 | — | $1.07 | $0.95 | -10.82% |
| ▼ Q2 FY2023 | Jun 1, 2023 | -22806.2% | $1.25 | $1.25 | +0.00% |
| — Q4 FY2022 | Dec 31, 2022 | — | $2.54 | $2.60 | +2.36% |
| — Q4 FY2022 | Nov 30, 2022 | — | $2.49 | $2.48 | -0.40% |
| ▼ Q2 FY2022 | May 30, 2022 | -100.0% | $2.11 | $1.90 | -9.95% |
| — Q1 FY2022 | Mar 31, 2022 | — | $3.05 | $3.05 | +0.00% |
| — Q4 FY2021 | Dec 31, 2021 | — | $2.92 | $3.15 | +7.88% |
Q4 FY2023+0.00%
Report Date
Nov 23, 2023
EPS Beat/Miss
-211.1%
Price Before
$0.24
Price After
$0.24
Q3 FY2023-10.82%
Report Date
Aug 25, 2023
EPS Beat/Miss
—
Price Before
$1.07
Price After
$0.95
Q2 FY2023+0.00%
Report Date
Jun 1, 2023
EPS Beat/Miss
-22806.2%
Price Before
$1.25
Price After
$1.25
Q4 FY2022+2.36%
Report Date
Dec 31, 2022
EPS Beat/Miss
—
Price Before
$2.54
Price After
$2.60
Q4 FY2022-0.40%
Report Date
Nov 30, 2022
EPS Beat/Miss
—
Price Before
$2.49
Price After
$2.48
Q2 FY2022-9.95%
Report Date
May 30, 2022
EPS Beat/Miss
-100.0%
Price Before
$2.11
Price After
$1.90
Q1 FY2022+0.00%
Report Date
Mar 31, 2022
EPS Beat/Miss
—
Price Before
$3.05
Price After
$3.05
Q4 FY2021+7.88%
Report Date
Dec 31, 2021
EPS Beat/Miss
—
Price Before
$2.92
Price After
$3.15
Avg Miss Reaction-3.32%
Beat Rate0 / 8 quarters
Largest Move-10.82% (Q3 FY2023)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: IWINF ends December
Irwin Naturals Inc. (IWINF) most recently reported earnings on November 23, 2023 for Q4 FY2023, posting EPS of $-0.56 — missing the analyst consensus of $-0.18 by -211.1%. The next IWINF earnings date is expected around September 1, 2026.
Each quarter, investors track IWINF earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. IWINF revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
IWINF's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
IWINF earnings · 5 questionsIrwin Naturals Inc.'s next earnings report is expected around September 1, 2026. IWINF typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; IWINF historically reports after market close (AMC).
IWINF earnings datewhen is IWINF earningsIWINF next earnings datewhen does IWINF report earningsIWINF earnings calendar
▸ Source: FMP · Irwin Naturals Inc. SEC filings · US GAAP · Irwin Naturals Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026